Crossmark

Lysophosphatidylcholine promoting α-Synuclein aggregation in Parkinson’s disease: disrupting GCase glycosylation and lysosomal α-Synuclein degradation

Crossref DOI link: https://doi.org/10.1038/s41531-025-00902-7

Published Online: 2025-03-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mu, Chunyan

Shao, Kaiquan

Su, Mingyu

Guo, Yurong

Qiu, Yuxiang

Sun, Ruiao

Sun, Sihan

Sun, Yaoyu

Liu, Chenkai

Wang, Wei

Qin, Xiaoling

Tang, Chuanxi
Funding

Funding for this research was provided by:

National Demonstration Center for Experimental Basic Medical Science Educatio (2024BMS09)

Jiangsu Province Scientific Research and Innovation Foundation (KYCX24-3114)

Research Foundation for Talented Scholars of Xuzhou Medical University (RC20552421, RC20552114)

Science and Technology Committee of Shanghai Hongkou District (220232)

Health Commission of Shanghai Hongkou District (HKQGYQY-XYY-2022-09)

National Natural Science Foundation of China (82101263)

Jiangsu Province Science Foundation for Youths (BK20210903)
License Information

Text and Data Mining valid from 2025-03-15

Version of Record valid from 2025-03-15
More Information

Article History

Received: 1 October 2024

Accepted: 6 March 2025

First Online: 15 March 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below